【结 构 式】 |
【分子编号】27907 【品名】Acetoacetic acid tert-butyl ester;3-Oxo-butanoic acid 1,1-dimethylethyl estertert-butyl 3-oxobutanoate 【CA登记号】1694-31-1 |
【 分 子 式 】C8H14O3 【 分 子 量 】158.19736 【元素组成】C 60.74% H 8.92% O 30.34% |
合成路线1
该中间体在本合成路线中的序号:(VII)Heating of 3,6-dichloropyridazine (I) with hydrazine hydrate at 100 C gives 6-chloro-3-pyridazinylhydrazine (II). The hydrazino group is protected by transforming it with camphor (III) to the camphorhydrazone (IV), which is aminated by heating with morpholine to give the morpholinylhydrazone (V). After liberating the hydrazine function by acidic hydrolysis in a biphasic system, the resulting 6-morpholino-3-pyridazinylhydrazine (VI) is reacted either with tert-butylacetoacetate (VII) or with tert-butylpropiolate (VIII) to yield RGH-5526.
【1】 Inoue, H.; Yoshida, M.; Aizawa, H.; et al.; Eur J Med Chem 1984, 19, 6, 111-117. |
【2】 Szilagyi, G.; et al. (Gedeon Richter Ltd.); Morpholino pyridazinylhydrazones. DE 2825861; FR 2394535; GB 2000125; HU 176972; JP 54016486; US 4259328; US 4308386 . |
【3】 Nogradi, M.; RGH-5526. Drugs Fut 1985, 10, 1, 32. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(A) | 10388 | Morpholine | 110-91-8 | C4H9NO | 详情 | 详情 |
(I) | 11292 | 3,6-Dichloropyridazine | 141-30-0 | C4H2Cl2N2 | 详情 | 详情 |
(II) | 28922 | 3-chloro-6-hydrazinopyridazine | 17284-97-8 | C4H5ClN4 | 详情 | 详情 |
(III) | 28926 | 1,7,7-trimethylbicyclo[2.2.1]heptan-2-one | 464-48-2 | C10H16O | 详情 | 详情 |
(IV) | 28923 | 1,7,7-trimethylbicyclo[2.2.1]heptan-2-one N-(6-chloro-3-pyridazinyl)hydrazone | C14H19ClN4 | 详情 | 详情 | |
(V) | 28924 | 1,7,7-trimethylbicyclo[2.2.1]heptan-2-one N-[6-(4-morpholinyl)-3-pyridazinyl]hydrazone | C18H27N5O | 详情 | 详情 | |
(VI) | 24847 | 4-(6-hydrazino-3-pyridazinyl)morpholine | C8H13N5O | 详情 | 详情 | |
(VII) | 27907 | Acetoacetic acid tert-butyl ester;3-Oxo-butanoic acid 1,1-dimethylethyl estertert-butyl 3-oxobutanoate | 1694-31-1 | C8H14O3 | 详情 | 详情 |
(VIII) | 28925 | tert-butyl propiolate | 13831-03-3 | C7H10O2 | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(IX)A synthesis of [14C]-labeled fluvastatin has been described: The acylation of fluorobenzene (I) with [14C]-bromoacetyl chloride (II) by means of AlCl3 gives the expected phenacyl bromide (III), which is condensed with N-isopropylaniline (IV) in hot ethanol yielding the tertiary amine (V). The cyclization of (V) by means of anhydrous ZnCl2 in refluxing ethanol affords the indole (VI), which is alkylated with 3-(N-methyl-N-phenylamino)acroleine (VII) by means of POCl3 in refluxing acetonitrile giving 3-[3-(4-fluorophenyl)-1-isopropylindol-2-yl]acroleine (VIII). The reductocondensation of (VIII) with tert-butyl acetoacetate (IX) by means of NaH and BuLi in THF yields 7-[3-(4-fluorophenyl)-1-isopropylindol-2-yl)-5-hydroxy-3-oxo-6-heptenoic acid tert-butyl ester (X), which is further reduced with NaBH4 and diethyl(methoxy)borane in THF to the dihydroxy compound (XI) as a mixture of the two syn-enantiomers (XI). Finally, this compound is hydrolyzed with NaOH in methanol to the expected sodium salt.
【1】 Jones, L.; Tang, Y.S.; Sunay, U.B.; Synthesis of carbon-14 labeled fluvastatin (Lescol(R)). J Label Compd Radiopharm 1998, 41, 1, 1. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 17466 | Fluorobenzene | 462-06-6 | C6H5F | 详情 | 详情 |
(II) | 27903 | 2-Bromoacetyl chloride | 22118-09-8 | C2H2BrClO | 详情 | 详情 |
(II) | 45080 | 2-bromoacetyl chloride | C2H2BrClO | 详情 | 详情 | |
(III) | 27904 | 2-bromo-1-(4-fluorophenyl)-1-ethanone | 403-29-2 | C8H6BrFO | 详情 | 详情 |
(III) | 45081 | 2-bromo-1-(4-fluorophenyl)-1-ethanone | C8H6BrFO | 详情 | 详情 | |
(IV) | 27905 | N-isopropyl-N-phenylamine | 768-52-5 | C9H13N | 详情 | 详情 |
(V) | 11787 | 1-(4-Fluorophenyl)-2-(isopropylanilino)-1-ethanone | C17H18FNO | 详情 | 详情 | |
(V) | 45082 | 1-(4-fluorophenyl)-2-(isopropylanilino)-1-ethanone | C17H18FNO | 详情 | 详情 | |
(VI) | 11788 | 3-(4-Fluorophenyl)-1-isopropyl-1H-indole | 93957-49-4 | C17H16FN | 详情 | 详情 |
(VI) | 45083 | 3-(4-fluorophenyl)-1-isopropyl-1H-indole | C17H16FN | 详情 | 详情 | |
(VII) | 27906 | (E)-3-(methylanilino)-2-propenal | C10H11NO | 详情 | 详情 | |
(VIII) | 11790 | (E)-3-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-2-propenal | C20H18FNO | 详情 | 详情 | |
(VIII) | 45084 | (E)-3-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-2-propenal | C20H18FNO | 详情 | 详情 | |
(IX) | 27907 | Acetoacetic acid tert-butyl ester;3-Oxo-butanoic acid 1,1-dimethylethyl estertert-butyl 3-oxobutanoate | 1694-31-1 | C8H14O3 | 详情 | 详情 |
(X) | 27908 | tert-butyl (E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-5-hydroxy-3-oxo-6-heptenoate | C28H32FNO4 | 详情 | 详情 | |
(X) | 45085 | tert-butyl (E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-5-hydroxy-3-oxo-6-heptenoate | C28H32FNO4 | 详情 | 详情 | |
(XI) | 27909 | tert-butyl (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoate | C28H34FNO4 | 详情 | 详情 | |
(XI) | 45086 | tert-butyl (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoate | C28H34FNO4 | 详情 | 详情 |
合成路线3
该中间体在本合成路线中的序号:(VIII)The Friedel-Crafts condensation of fluorobenzene (I) with chloroacetyl chloride (II) by means of AlCl3 gives the phenacyl chloride (III), which is cyclized with N-isopropylaniline (IV) by means of ZnCl2 to yield 3-(4-fluorophenyl)-1-isopropyl-1H-indole (V). The condensation of (V) with 3-(N-methyl-N-phenylamino)acrolein (VI) by means of POCl3 in acetonitrile affords 3-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]acrolein (VII), which is further condensed with tert-butyl acetoacetate (VIII) by means of BuLi and NaH in THF to provide 7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-5-hydroxy-3-oxo-6(E)-heptenoic acid tert-butyl ester (IX). The reduction of the ketonic group of (IX) with NaBH4 catalyzed by Et2B-OMe as chelating agent gives the diol (X) with a syn configuration. Finally, the tert-butyl ester group of (X) is hydrolyzed with NaOH in ethanol/water to afford the target fluvastatin sodium.
【1】 Repic, O.; et al.; The story of Lescol: From research to production. Org Process Res Dev 2001, 5, 5, 519. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 17466 | Fluorobenzene | 462-06-6 | C6H5F | 详情 | 详情 |
(II) | 11296 | 2-Chloroacetyl chloride; Chloroacetic chloride | 79-04-9 | C2H2Cl2O | 详情 | 详情 |
(III) | 11786 | 2-Chloro-1-(4-fluorophenyl)-1-ethanone; 2-Chloro-4'-fluoroacetophenone | 456-04-2 | C8H6ClFO | 详情 | 详情 |
(IV) | 27905 | N-isopropyl-N-phenylamine | 768-52-5 | C9H13N | 详情 | 详情 |
(V) | 11788 | 3-(4-Fluorophenyl)-1-isopropyl-1H-indole | 93957-49-4 | C17H16FN | 详情 | 详情 |
(VI) | 27906 | (E)-3-(methylanilino)-2-propenal | C10H11NO | 详情 | 详情 | |
(VII) | 11790 | (E)-3-[3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl]-2-propenal | C20H18FNO | 详情 | 详情 | |
(VIII) | 27907 | Acetoacetic acid tert-butyl ester;3-Oxo-butanoic acid 1,1-dimethylethyl estertert-butyl 3-oxobutanoate | 1694-31-1 | C8H14O3 | 详情 | 详情 |
(IX) | 27908 | tert-butyl (E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-5-hydroxy-3-oxo-6-heptenoate | C28H32FNO4 | 详情 | 详情 | |
(X) | 27909 | tert-butyl (3R,5S,6E)-7-[3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl]-3,5-dihydroxy-6-heptenoate | C28H34FNO4 | 详情 | 详情 |
合成路线4
该中间体在本合成路线中的序号:(XVII)In an alternative route to the title compound, dinitro derivative (XV) was converted into the benzofuroxan (XVI) by treatment with sodium azide in hot DMSO. Furazan ring opening by means of tert-butyl acetoacetate (XVII) under basic conditions generated the quinoxaline N,N'-dioxide (XVIII). The Pummerer-like rearrangement of the N-oxide (XVIII) in the presence of trifluoroacetic anhydride gave rise to the unstable trifluoroacetoxymethyl quinoxaline (XIX), which was further converted to bromide (XX) upon heating with LiBr in acetone. Alkylation of N,N-di-Boc-hydroxylamine (III) with bromide (XX) provided the protected O-alkyl hydroxylamine (XXI). Reduction of the remaining N-oxide group of (XXI) and simultaneous N-Boc groups cleavage by means of boron tribromide furnished quinoxaline (XXII). The fully deprotected quinoxaline (IX) was then obtained by acidic treatment of (XXII). Condensation of keto amide (XIII) with hydroxylamine (IX) in the presence of tetrabutylammonium bisulfate produced the oxime adduct (XXIII). Finally, the title compound was obtained by deformylation of (XXIII) under acidic conditions.
【1】 Koster, W.H.; Sundeen, J.E.; Straub, H.; Ermann, P.H.; Treuner, U. (Bristol-Myers Squibb Co.); Heteroaroyl derivs. of monocyclic beta-lactam antibiotics. EP 0484881; JP 1992283579 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(III) | 58719 | 2-({[(tert-butoxycarbonyl)(hydroxy)amino]carbonyl}oxy)-2-methylpropane | C10H19NO5 | 详情 | 详情 | |
(IX) | 58725 | 3-[(aminooxy)methyl]-6,7-dihydroxy-2-quinoxalinecarboxylic acid | C10H9N3O5 | 详情 | 详情 | |
(XIII) | 58728 | N,N,N-tributyl-1-butanaminium (2R,3S)-3-({2-[2-(formylamino)-1,3-thiazol-4-yl]-2-oxoacetyl}amino)-2-methyl-4-oxo-1-azetidinesulfonate | C26H45N5O7S2 | 详情 | 详情 | |
(XV) | 58730 | 2,2-dimethyl-5,6-dinitro-1,3-benzodioxole | C9H8N2O6 | 详情 | 详情 | |
(XVI) | 58731 | 6,6-dimethyl[1,3]dioxolo[4,5-f][2,1,3]benzoxadiazol-1-ium-1-olate | C9H8N2O4 | 详情 | 详情 | |
(XVII) | 27907 | Acetoacetic acid tert-butyl ester;3-Oxo-butanoic acid 1,1-dimethylethyl estertert-butyl 3-oxobutanoate | 1694-31-1 | C8H14O3 | 详情 | 详情 |
(XVIII) | 58732 | 6-(tert-butoxycarbonyl)-2,2,7-trimethyl[1,3]dioxolo[4,5-g]quinoxaline-5,8-diium-5,8-diolate | C17H20N2O6 | 详情 | 详情 | |
(XIX) | 58733 | 6-(tert-butoxycarbonyl)-2,2-dimethyl-7-{[(2,2,2-trifluoroacetyl)oxy]methyl}[1,3]dioxolo[4,5-g]quinoxalin-5-ium-5-olate | C19H19F3N2O7 | 详情 | 详情 | |
(XX) | 58734 | 7-(bromomethyl)-6-(tert-butoxycarbonyl)-2,2-dimethyl[1,3]dioxolo[4,5-g]quinoxalin-5-ium-5-olate | C17H19BrN2O5 | 详情 | 详情 | |
(XXI) | 58735 | 7-({[bis(tert-butoxycarbonyl)amino]oxy}methyl)-6-(tert-butoxycarbonyl)-2,2-dimethyl[1,3]dioxolo[4,5-g]quinoxalin-5-ium-5-olate | C27H37N3O10 | 详情 | 详情 | |
(XXII) | 58736 | tert-butyl 7-[(aminooxy)methyl]-2,2-dimethyl[1,3]dioxolo[4,5-g]quinoxaline-6-carboxylate | C17H21N3O5 | 详情 | 详情 | |
(XXIII) | 58737 | di(N,N,N-tributyl-1-butanaminium) 3-({[((Z)-1-[2-(formylamino)-1,3-thiazol-4-yl]-2-{[(2R,3S)-2-methyl-4-oxo-1-sulfonatoazetidinyl]amino}-2-oxoethylidene)amino]oxy}methyl)-6,7-dihydroxy-2-quinoxalinecarboxylate | C52H87N9O11S2 | 详情 | 详情 |
合成路线5
该中间体在本合成路线中的序号:(I)Nitrosation of tert-butyl acetoacetate (I) with NaNO2/AcOH produces the oximino ester (II). Reductive cyclization of (II) with ethyl acetoacetate (III) in the presence of Zn/AcOH leads to the pyrrole dicarboxylate (IV). Selective decarboxylation of the t-butyl ester of (IV) under acidic conditions, followed by Vilsmeier formylation of the intermediate ethyl 2,4-dimethylpyrrole-3-carboxylate furnishes the pyrrole aldehyde (V). Alternatively, this compound is directly obtained from (IV) upon treatment with trimethyl orthoformate and trifluoroacetic acid. Basic hydrolysis of the ethyl ester group of (V) yields the pyrrolecarboxylic acid (VI). This is coupled to 2-(diethylamino)ethylamine (VII) to afford the corresponding amide (VIII).
【1】 Sun, L.; Liang, C.; Shirazian, S.; Zhou, Y.; Miller, T.; Ciu, J.; Fukuda, J.Y.; Chu, J.-Y.; Nematalla, A.; Wang, X.; Chen, H.; Sistla, A.; Luu, T.C.; Tang, F.; Wei, J.; Tang, C.; Discovery of 5-[5-fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine. J Med Chem 2003, 46, 7, 1116. |
【2】 Wei, C.C.; Miller, T.; Tang, P.C.; Nematalla, A.S.; Li, X.; Liang, C.; Shirazian, S.; Su, L.; Vojkovsky, T. (Sugen, Inc.); Pyrrole substd. 2-indolinone protein kinase inhibitors. EP 1255752; US 2002156292; US 6573293; WO 0160814 . |
【3】 Shenoy, N.; Sorasuchart, W. (Sugen, Inc.); Formulations for pharmaceutical agents ionizable as free acids or free bases. JP 2003514851; WO 0137820 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 27907 | Acetoacetic acid tert-butyl ester;3-Oxo-butanoic acid 1,1-dimethylethyl estertert-butyl 3-oxobutanoate | 1694-31-1 | C8H14O3 | 详情 | 详情 |
(II) | 63353 | 1,1-dimethylethyl 2-(hydroxyimino)-3-oxobutanoate | 14352-65-9 | C8H13NO4 | 详情 | 详情 |
(III) | 11819 | ethyl acetoacetate; ethyl 3-oxobutanoate;Acetoacetic ester;Ethyl beta-ketobutyrate;ethyl 3-oxobutyrate | 141-97-9 | C6H10O3 | 详情 | 详情 |
(IV) | 63354 | 2-(1,1-dimethylethyl) 4-ethyl 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate | 86770-31-2 | C14H21NO4 | 详情 | 详情 |
(V) | 60381 | ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate | 2199-59-9 | C10H13NO3 | 详情 | 详情 |
(VI) | 60382 | 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | 253870-02-9 | C8H9NO3 | 详情 | 详情 |
(VII) | 12420 | N-(2-Aminoethyl)-N,N-diethylamine; N,N-Diethylethylene-diamine; N(1),N(1)-Diethyl-1,2-ethanediamine | 100-36-7 | C6H16N2 | 详情 | 详情 |
(VIII) | 63355 | N-[2-(diethylamino)ethyl]-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide | 356068-86-5 | C14H23N3O2 | 详情 | 详情 |
合成路线6
该中间体在本合成路线中的序号:(I)Nitrosation of tert-butyl acetoacetate (I) with NaNO2 in cold AcOH leads to oxime (II), which is further condensed with benzyl acetoacetate (III) in the presence of Zn and ammonium acetate, to produce pyrrole (IV). The 4-benzyl ester of (IV) is selectively removed by catalytic hydrogenolysis over Pd/C, yielding the pyrrole-4-carboxylic acid (V). Subsequent coupling of acid (V) with 3,3-dimethyl-2-butanol (VI) employing trifluoroacetic anhydride furnishes the target pyrrole diester.
【1】 Synthesis and pharmacological characterisation of 2,4-dicarboxy-pyrroles as selective non-competitive mGluR1 antagonists. Bioorg Med Chem 2003, 11, 2, 171. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 27907 | Acetoacetic acid tert-butyl ester;3-Oxo-butanoic acid 1,1-dimethylethyl estertert-butyl 3-oxobutanoate | 1694-31-1 | C8H14O3 | 详情 | 详情 |
(II) | 63353 | 1,1-dimethylethyl 2-(hydroxyimino)-3-oxobutanoate | 14352-65-9 | C8H13NO4 | 详情 | 详情 |
(III) | 65102 | benzyl 3-oxobutanoate | C11H12O3 | 详情 | 详情 | |
(IV) | 65101 | 4-benzyl 2-(tert-butyl) 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate | C19H23NO4 | 详情 | 详情 | |
(V) | 65100 | 5-(tert-butoxycarbonyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | C12H17NO4 | 详情 | 详情 | |
(VI) | 65099 | 3,3-dimethyl-2-butanol | C6H14O | 详情 | 详情 |
合成路线7
该中间体在本合成路线中的序号:(III)
【1】 Jin QW, Mnuragis MA, May PD. 2003. Process for preparing aminocarbonylpyrrolylmethylideneindolinones from indolinones, imidazolcarbonylpyrrolecarboxaldehydes, and amines. W0 2003070725 |
【2】 Manley JM, Kalman MJ, Conway BG, et al. 2003. Early amidation approach to 3-[(4-anudo)pyrrol-2-yl]-2-indolinones. J Org Cbem, 68(16):6447~6450 |
【3】 Wang JQ, Miller KD, Sledge GW, et aL. 2005. Synthesis of [18F] SU11248, a new potential PET tracer for imaging cancer tyrosine kinase. Bioorg Med Chem lett, 15(19): 4380~4384 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(IX) | 60384 | 5-fluoro-1,3-dihydro-2H-indol-2-one | 56341-41-4 | C8H6FNO | 详情 | 详情 |
(I) | 11367 | 4-Methylene-2-oxetanone; Acetyl ketene | 674-82-8 | C4H4O2 | 详情 | 详情 |
(II) | 66748 | N-(2-(diethylamino)ethyl)-3-oxobutanamide | C10H20N2O2 | 详情 | 详情 | |
(III) | 27907 | Acetoacetic acid tert-butyl ester;3-Oxo-butanoic acid 1,1-dimethylethyl estertert-butyl 3-oxobutanoate | 1694-31-1 | C8H14O3 | 详情 | 详情 |
(IV) | 63353 | 1,1-dimethylethyl 2-(hydroxyimino)-3-oxobutanoate | 14352-65-9 | C8H13NO4 | 详情 | 详情 |
(V) | 66749 | tert-butyl 4-((2-(diethylamino)ethyl)carbamoyl)-3,5-dimethyl-1H-pyrrole-2-carboxylate | C18H31N3O3 | 详情 | 详情 | |
(VI) | 66750 | N-(2-(diethylamino)ethyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide | C13H23N3O | 详情 | 详情 | |
(VII) | 17643 | (Chloromethylene)dimethylammonium chloride; N-(chloromethylene)-N-methylmethanaminium chloride | 3724-43-4 | C3H7Cl2N | 详情 | 详情 |
(VIII) | 66751 | N-((4-((2-(diethylamino)ethyl)carbamoyl)-3,5-dimethyl-1H-pyrrol-2-yl)methylene)-N-methylmethanaminium chloride | C16H29ClN4O | 详情 | 详情 | |
(X) | 66752 | (Z)-N-[2-(Diethylamino)ethyl]-5-(5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide | 326914-13-0 | C22H27FN4O2 | 详情 | 详情 |
合成路线8
该中间体在本合成路线中的序号:(I)
【1】 Jin QW, Mnuragis MA, May PD. 2003. Process for preparing aminocarbonylpyrrolylmethylideneindolinones from indolinones, imidazolcarbonylpyrrolecarboxaldehydes, and amines. W0 2003070725 |
【2】 Manley JM, Kalman MJ, Conway BG, et al. 2003. Early amidation approach to 3-[(4-anudo)pyrrol-2-yl]-2-indolinones. J Org Cbem, 68(16):6447~6450 |
【3】 Sun L, Liang C, Shirazian S, et aL. 2003. Discovery of 5-[5-Fluoro-2-oxo-l,2-dihydroindol-(3Z)-ylidenemethyl}2,4一dimethyl-lH-pyrrole-3-carboxylic acid (2-diethylaminoethyl) amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase. J Med Chem, 46(7): 1116~1119 |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(II) | 63353 | 1,1-dimethylethyl 2-(hydroxyimino)-3-oxobutanoate | 14352-65-9 | C8H13NO4 | 详情 | 详情 |
(VIII) | 14754 | ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine | 107-15-3 | C2H8N2 | 详情 | 详情 |
(IX) | 66753 | (E)-N-(2-(diethylamino)ethyl)-5-(((2-(diethylamino)ethyl)imino)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide | C20H37N5O | 详情 | 详情 | |
(X) | 60384 | 5-fluoro-1,3-dihydro-2H-indol-2-one | 56341-41-4 | C8H6FNO | 详情 | 详情 |
(XI) | 66752 | (Z)-N-[2-(Diethylamino)ethyl]-5-(5-fluoro-2-oxo-2,3-dihydro-1H-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide | 326914-13-0 | C22H27FN4O2 | 详情 | 详情 |
(I) | 27907 | Acetoacetic acid tert-butyl ester;3-Oxo-butanoic acid 1,1-dimethylethyl estertert-butyl 3-oxobutanoate | 1694-31-1 | C8H14O3 | 详情 | 详情 |
(III) | 11819 | ethyl acetoacetate; ethyl 3-oxobutanoate;Acetoacetic ester;Ethyl beta-ketobutyrate;ethyl 3-oxobutyrate | 141-97-9 | C6H10O3 | 详情 | 详情 |
(IV) | 63354 | 2-(1,1-dimethylethyl) 4-ethyl 3,5-dimethyl-1H-pyrrole-2,4-dicarboxylate | 86770-31-2 | C14H21NO4 | 详情 | 详情 |
(V) | 60380 | ethyl 2,4-dimethyl-1H-pyrrole-3-carboxylate | 2199-51-1 | C9H13NO2 | 详情 | 详情 |
(VI) | 60381 | ethyl 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylate | 2199-59-9 | C10H13NO3 | 详情 | 详情 |
(VII) | 60382 | 5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxylic acid | 253870-02-9 | C8H9NO3 | 详情 | 详情 |
合成路线9
该中间体在本合成路线中的序号:(I)
【1】 Lopez M,Rodriguez Z,Gonzalez M,et al.Synthesis of (Z)-2-(2-formamido-4-thiazolyl)-2-(substituted alkoxyimino)acetic acids.Farmaco,2000,55:40. |
【2】 Parthasaradhi Reddy B,Rathnakar Reddy K,Raji Reddy R,et al.An improved process for the preparation of ceficime:WO,Patent 2,006,103,686,2006. |
【3】 程先波,胡立蓬,叶树祥,等.头孢克肟的制备方法:CN,Patent 101,319,246,2008. |
【4】 潘行远.一种头孢克肟的合成方法:CN,Patent 101,016,305,2007. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 27907 | Acetoacetic acid tert-butyl ester;3-Oxo-butanoic acid 1,1-dimethylethyl estertert-butyl 3-oxobutanoate | 1694-31-1 | C8H14O3 | 详情 | 详情 |
(II) | 69635 | (Z)-tert-butyl 2-(hydroxyimino)-3-oxobutanoate | C8H13NO4 | 详情 | 详情 | |
(III) | 69636 | (Z)-tert-butyl 2-((2-methoxy-2-oxoethoxy)imino)-3-oxobutanoate | C11H17NO6 | 详情 | 详情 | |
(IV) | 69637 | 4-Chloro-2-[(2-methoxy-2-oxoethoxy)imino]-3-oxobutanoic acid;4-Chloro-2-(Z)-methoxycarbonylmethoxyimino-3-oxobutyric acid;(Z)-4-chloro-2-((2-methoxy-2-oxoethoxy)imino)-3-oxobutanoic acid | 95759-10-7 | C7H8ClNO6 | 详情 | 详情 |
(V) | 69638 | (Z)-2-(2-aminothiazol-4-yl)-2-((2-methoxy-2-oxoethoxy)imino)acetic acid | 80544-17-8 | C8H9N3O5S | 详情 | 详情 |
(VI) | 69639 | (Z)-methyl 2-(((1-(2-aminothiazol-4-yl)-2-(benzo[d]thiazol-2-ylthio)-2-oxoethylidene)amino)oxy)acetate | 246035-38-1 | C15H12N4O4S3 | 详情 | 详情 |
(VII) | 69640 | (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-((2-methoxy-2-oxoethoxy)imino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | C17H17N5O7S2 | 详情 | 详情 | |
(VIII) | 10257 | methyl 2-chloroacetate; methyl chloroacetate | 96-34-4 | C3H5ClO2 | 详情 | 详情 |
(IX) | 10180 | Thiourea | 62-56-6 | CH4N2S | 详情 | 详情 |
(X) | 64882 | (6R,7R)-7-amino-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | 79349-82-9 | C9H10N2O3S | 详情 | 详情 |